This comprehensive worldwide study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the U.S., Europe and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.
